Salmeterol in the management of paediatric asthma.
作者信息
Jones K
出版信息
Respir Med. 1994 Oct;88(9):639-43. doi: 10.1016/s0954-6111(05)80059-9.
PMID:7809435
Abstract
摘要
相似文献
1
Salmeterol in the management of paediatric asthma.
Respir Med. 1994 Oct;88(9):639-43. doi: 10.1016/s0954-6111(05)80059-9.
2
Practical pharmacotherapy for pediatric asthma.儿童哮喘的实用药物治疗
Pediatr Ann. 2000 Dec;29(12):768-73. doi: 10.3928/0090-4481-20001201-11.
3
Salmeterol: its place in asthma management.
Ann Pharmacother. 1994 Sep;28(9):1100-2. doi: 10.1177/106002809402800916.
4
Asthma group issues guidelines for safe use of salmeterol.
Am J Health Syst Pharm. 1996 Dec 15;53(24):2943-4. doi: 10.1093/ajhp/53.24.2943.
5
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.口服孟鲁司特与吸入沙美特罗预防运动诱发性支气管收缩的比较
Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00020.
6
Salmeterol: a novel, long-acting beta 2-agonist.沙美特罗：一种新型长效β2受体激动剂。
Ann Pharmacother. 1993 Dec;27(12):1478-87. doi: 10.1177/106002809302701214.
7
Salmeterol xinafoate in asthma.
JAMA. 1994;272(20):1575-6. doi: 10.1001/jama.272.20.1575a.
8
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.口服孟鲁司特与吸入沙美特罗预防运动诱发性支气管收缩的比较。
Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00019.
9
Life-threatening asthma during treatment with salmeterol.沙美特罗治疗期间的危及生命的哮喘。
N Engl J Med. 2006 Aug 24;355(8):852-3. doi: 10.1056/NEJMc066282.
10
The Salmeterol Multicenter Asthma Research Trial.
Chest. 2006 Sep;130(3):928; author reply 928-9. doi: 10.1378/chest.130.3.928.
Zotero 插件